List of works - Anders Ettrup

11C-NS14492 as a novel PET radioligand for imaging cerebral alpha7 nicotinic acetylcholine receptors: in vivo evaluation and drug occupancy measurements

scientific article published on 9 August 2011

Acute social defeat does not alter cerebral 5-HT2A receptor binding in male Wistar rats

scientific article

Adeno-associated viral vector serotypes 1 and 5 targeted to the neonatal rat and pig striatum induce widespread transgene expression in the forebrain

scientific article

An approach for serotonin depletion in pigs: effects on serotonin receptor binding

scientific article published on February 2011

Blood BDNF concentrations reflect brain-tissue BDNF levels across species

scientific article

Cerebral 5-HT release correlates with [(11)C]Cimbi36 PET measures of 5-HT2A receptor occupancy in the pig brain

scientific article (publication date: February 2017)

Cerebral markers of the serotonergic system in rat models of obesity and after Roux-en-Y gastric bypass

scientific article published on 26 March 2012

Characterization of [(11)C]Cimbi-36 as an agonist PET radioligand for the 5-HT(2A) and 5-HT(2C) receptors in the nonhuman primate brain

scientific article published on 28 August 2013

Cognitive performance of Göttingen minipigs is affected by diet in a spatial hole-board discrimination test

scientific article

Cognitive symptoms in major depressive disorder: associations with clinical and functional outcomes in a 6-month, non-interventional, prospective study in China

scientific article published on 01 July 2019

Comparison of ultrafiltration and equilibrium dialysis for estimation of protein binding

Design of Infusion Schemes for Neuroreceptor Imaging: Application to [(11)C]Flumazenil-PET Steady-State Study

scientific article published on 31 March 2016

Design, synthesis, radiolabeling and in vivo evaluation of potential positron emission tomography (PET) radioligands for brain imaging of the 5-HT₇ receptor

scientific article

Direct comparison of [(18) F]MH.MZ and [(18) F] altanserin for 5-HT2A receptor imaging with PET.

scientific article published on 7 March 2013

Evaluation of 3-Ethyl-3-(phenylpiperazinylbutyl)oxindoles as PET Ligands for the Serotonin 5-HT₇ Receptor: Synthesis, Pharmacology, Radiolabeling, and in Vivo Brain Imaging in Pigs

scientific article published on 13 April 2015

Fenfluramine Reduces [11C]Cimbi-36 Binding to the 5-HT2A Receptor in the Nonhuman Primate Brain

scientific article published on September 2017

Improvements in Workplace Productivity in Working Patients With Major Depressive Disorder: Results From the AtWoRC Study

scientific article published on 01 March 2020

In vivo evaluation of a series of substituted 11C-phenetylamines as 5-HT2A agonist PET tracers

Intravenous vortioxetine to accelerate onset of effect in major depressive disorder: a 2-week, randomized, double-blind, placebo-controlled study

scientific article published on 01 July 2019

Intravenous vortioxetine to accelerate onset of effect in major depressive disorder: a 7-day randomized, double-blind, placebo-controlled exploratory study

scientific article published on 07 August 2020

Long-term functioning outcomes are predicted by cognitive symptoms in working patients with major depressive disorder treated with vortioxetine: results from the AtWoRC study

scientific article published on 01 December 2019

Measuring endogenous changes in serotonergic neurotransmission with [C]Cimbi-36 positron emission tomography in humans

No change in [¹¹C]CUMI-101 binding to 5-HT(1A) receptors after intravenous citalopram in human

scientific article published on 20 July 2012

Patient-reported depression severity and cognitive symptoms as determinants of functioning in patients with major depressive disorder: a secondary analysis of the 2-year prospective PERFORM study

scientific article published on 13 August 2019

Pharmacokinetics and Safety of Vortioxetine in the Chinese Population

scientific article published on 24 September 2019

Plaque deposition dependent decrease in 5-HT2A serotonin receptor in AbetaPPswe/PS1dE9 amyloid overexpressing mice

scientific article published in January 2010

Preclinical safety assessment of the 5-HT2A receptor agonist PET radioligand [ 11C]Cimbi-36.

scientific article

Radiolabelling and PET brain imaging of the α₁-adrenoceptor antagonist Lu AE43936.

scientific article published on 17 November 2012

Radiosynthesis and evaluation of 11C-CIMBI-5 as a 5-HT2A receptor agonist radioligand for PET.

scientific article

Radiosynthesis and in vitro validation of (3)H-NS14492 as a novel high affinity alpha7 nicotinic receptor radioligand

scientific article published in May 2015

Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT (2A) agonist PET tracers

scientific article

Radiosynthesis and in vivo evaluation of novel radioligands for PET imaging of cerebral 5-HT7 receptors.

scientific article published on 24 February 2014

Relationship between response to aripiprazole once-monthly and paliperidone palmitate on work readiness and functioning in schizophrenia: A post-hoc analysis of the QUALIFY study

scientific article published on 24 August 2017

Serotonin 2A receptor agonist binding in the human brain with [(11)C]Cimbi-36: Test-retest reproducibility and head-to-head comparison with the antagonist [(18)F]altanserin

scientific article

Serotonin 2A receptor agonist binding in the human brain with [¹¹C]Cimbi-36.

scientific article

Similar serotonin-2A receptor binding in rats with different coping styles or levels of aggression

scientific article

Successfully treated patients with vortioxetine versus venlafaxine: a simplified cost-effectiveness analysis based on a head-to-head study in Asian patients with major depressive disorder

scientific article published on 13 February 2020

Synthesis and evaluation of (18)F-labeled 5-HT2A receptor agonists as PET ligands

scientific article published on 19 April 2016

Synthesis and evaluation of [¹¹C]Cimbi-806 as a potential PET ligand for 5-HT₇ receptor imaging

scientific article published on 18 May 2012

Synthesis, radiofluorination, and preliminary evaluation of the potential 5-HT2A receptor agonists [18 F]Cimbi-92 and [18 F]Cimbi-150.

scientific article published on 30 August 2017

Synthesis, radiolabeling and in vivo evaluation of [(11)C](R)-1-[4-[2-(4-methoxyphenyl)phenyl]piperazin-1-yl]-3-(2-pyrazinyloxy)-2-propanol, a potential PET radioligand for the 5-HT(7) receptor

scientific article published on 29 March 2014

The Center for Integrated Molecular Brain Imaging (Cimbi) database ⬇️

scientific article

Vortioxetine for attention deficit hyperactivity disorder in adults: A randomized, double-blind, placebo-controlled, proof-of-concept study

scientific article published on 07 March 2019

List of works by Anders Ettrup

11C-NS14492 as a novel PET radioligand for imaging cerebral alpha7 nicotinic acetylcholine receptors: in vivo evaluation and drug occupancy measurements

Acute social defeat does not alter cerebral 5-HT2A receptor binding in male Wistar rats

Adeno-associated viral vector serotypes 1 and 5 targeted to the neonatal rat and pig striatum induce widespread transgene expression in the forebrain

An approach for serotonin depletion in pigs: effects on serotonin receptor binding

Blood BDNF concentrations reflect brain-tissue BDNF levels across species

Cerebral 5-HT release correlates with [(11)C]Cimbi36 PET measures of 5-HT2A receptor occupancy in the pig brain

Cerebral markers of the serotonergic system in rat models of obesity and after Roux-en-Y gastric bypass

Characterization of [(11)C]Cimbi-36 as an agonist PET radioligand for the 5-HT(2A) and 5-HT(2C) receptors in the nonhuman primate brain

Cognitive performance of Göttingen minipigs is affected by diet in a spatial hole-board discrimination test

Cognitive symptoms in major depressive disorder: associations with clinical and functional outcomes in a 6-month, non-interventional, prospective study in China

Comparison of ultrafiltration and equilibrium dialysis for estimation of protein binding

Design of Infusion Schemes for Neuroreceptor Imaging: Application to [(11)C]Flumazenil-PET Steady-State Study

Design, synthesis, radiolabeling and in vivo evaluation of potential positron emission tomography (PET) radioligands for brain imaging of the 5-HT₇ receptor

Direct comparison of [(18) F]MH.MZ and [(18) F] altanserin for 5-HT2A receptor imaging with PET.

Evaluation of 3-Ethyl-3-(phenylpiperazinylbutyl)oxindoles as PET Ligands for the Serotonin 5-HT₇ Receptor: Synthesis, Pharmacology, Radiolabeling, and in Vivo Brain Imaging in Pigs

Fenfluramine Reduces [11C]Cimbi-36 Binding to the 5-HT2A Receptor in the Nonhuman Primate Brain

Improvements in Workplace Productivity in Working Patients With Major Depressive Disorder: Results From the AtWoRC Study

In vivo evaluation of a series of substituted 11C-phenetylamines as 5-HT2A agonist PET tracers

Intravenous vortioxetine to accelerate onset of effect in major depressive disorder: a 2-week, randomized, double-blind, placebo-controlled study

Intravenous vortioxetine to accelerate onset of effect in major depressive disorder: a 7-day randomized, double-blind, placebo-controlled exploratory study

Long-term functioning outcomes are predicted by cognitive symptoms in working patients with major depressive disorder treated with vortioxetine: results from the AtWoRC study

Measuring endogenous changes in serotonergic neurotransmission with [C]Cimbi-36 positron emission tomography in humans

No change in [¹¹C]CUMI-101 binding to 5-HT(1A) receptors after intravenous citalopram in human

Patient-reported depression severity and cognitive symptoms as determinants of functioning in patients with major depressive disorder: a secondary analysis of the 2-year prospective PERFORM study

Pharmacokinetics and Safety of Vortioxetine in the Chinese Population

Plaque deposition dependent decrease in 5-HT2A serotonin receptor in AbetaPPswe/PS1dE9 amyloid overexpressing mice

Preclinical safety assessment of the 5-HT2A receptor agonist PET radioligand [ 11C]Cimbi-36.

Radiolabelling and PET brain imaging of the α₁-adrenoceptor antagonist Lu AE43936.

Radiosynthesis and evaluation of 11C-CIMBI-5 as a 5-HT2A receptor agonist radioligand for PET.

Radiosynthesis and in vitro validation of (3)H-NS14492 as a novel high affinity alpha7 nicotinic receptor radioligand

Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT (2A) agonist PET tracers

Radiosynthesis and in vivo evaluation of novel radioligands for PET imaging of cerebral 5-HT7 receptors.

Relationship between response to aripiprazole once-monthly and paliperidone palmitate on work readiness and functioning in schizophrenia: A post-hoc analysis of the QUALIFY study

Serotonin 2A receptor agonist binding in the human brain with [(11)C]Cimbi-36: Test-retest reproducibility and head-to-head comparison with the antagonist [(18)F]altanserin

Serotonin 2A receptor agonist binding in the human brain with [¹¹C]Cimbi-36.

Similar serotonin-2A receptor binding in rats with different coping styles or levels of aggression

Successfully treated patients with vortioxetine versus venlafaxine: a simplified cost-effectiveness analysis based on a head-to-head study in Asian patients with major depressive disorder

Synthesis and evaluation of (18)F-labeled 5-HT2A receptor agonists as PET ligands

Synthesis and evaluation of [¹¹C]Cimbi-806 as a potential PET ligand for 5-HT₇ receptor imaging

Synthesis, radiofluorination, and preliminary evaluation of the potential 5-HT2A receptor agonists [18 F]Cimbi-92 and [18 F]Cimbi-150.

Synthesis, radiolabeling and in vivo evaluation of [(11)C](R)-1-[4-[2-(4-methoxyphenyl)phenyl]piperazin-1-yl]-3-(2-pyrazinyloxy)-2-propanol, a potential PET radioligand for the 5-HT(7) receptor

The Center for Integrated Molecular Brain Imaging (Cimbi) database ⬇️

Vortioxetine for attention deficit hyperactivity disorder in adults: A randomized, double-blind, placebo-controlled, proof-of-concept study